Searchable abstracts of presentations at key conferences in endocrinology

ea0035p892 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Pituitary incidentaloma: an age-related study in 266 Romanian patients

Poiana Catalina , Carsote Mara , Ene Cristina , Mihai Alexandra , Dumitrascu Anda , Dusceac Roxana , Niculescu Dan , Peretianu Dan

Introduction: The pituitary tumors which are considered pituitary incidentalomas are accidentally discovered at pituitary scan and they associate a lack of pituitary hyper-secretion. Opposite to what generally are considered for adrenal incidentalomas, the pituitary incidentalomas are more frequent with years of life.Aim: We analyzed the incidentaloma sizes related to decades of age.Material and method: This is a retrospective stud...

ea0081ep1076 | Thyroid | ECE2022

Autoimmune thyroiditis after 2 years covid pandemic: prevalence, clinical features, significance. Study on 450 patients in a medical center of Bucharest-Romania

Peretianu Dan , Stanciu Mihaela , Dana Oprea Cristina

Material-Method: We registered from February 26, 2020 until January 23, 2022 (almost 2 years) patients with chronic autoimmune thyroiditis Hashimoto. Usual parameters for this disease were investigated: age, sex, ATPO, FT4, TSH, ultrasound pattern, antibody evolution, immune associations, lost pregnancies, other clinical associations (alergies, breast cancer). Patients were divided into 2 groups: those who had covid-19 (C-19) vs. those who did not have viral disease (<u...

ea0049ep1157 | Male Reproduction | ECE2017

Analysing by decade, testosterone undecanoat depot injectable does not increases prostate volume. Study during up to 9 years on hypogonadic patients. (December 2016)

Pisoschi Matei , Cristina Staicu Dana , Peretianu Dan

Aim: Re-analyzing (study starting in 2007) the effect of injectable testosterone undecanoat depot (TUD) in hypogonadic patients.Materials and Methods: A. Patients: at onset 231 men with hypogonadism (median: 62 y). B. Distribution: by decade (starting with 20y); no =4, 14, 24, 61, 63, 49, 17, 1. C. TUD (NebidoR-Bayer) 1000 mg injected one/3 months i.m. D. Prostate volume (PV) appreciated by per-abdominal ultrasound: 3.5–5 MHz probe, ellip...

ea0070ep430 | Thyroid | ECE2020

Antithyroperoxydase autoantibody evolution in Hashimoto thyroiditis. Comparison between all re-evaluated patients and those over 10 years observation. January 2020

Peretianu Dan , Cristina Staicu Dana , Oprisan Bogdan

Aim: Most research teams analyze the evolution of patients with Hashimoto thyroiditis (HT) on syndromic basis (e.g., the thyroid function), not on pathogenic basis (the autoantibodies). Thus, most researchers refer to thyroid hormone evolution. In this study we re-analyzed (first in 2018) how evolve the antithyroid autoantibodies. Therefore, we analyzed the antithyroperoxydase antibodies (ATPO) evolutive patterns in patients with HT.Method: 1. ATPO level...

ea0032p662 | Male reproduction | ECE2013

Testosterone undecanoate 1000 mg at 3 months does not increase prostatic specific antigen level: study on over 100 patients, December 2012

Pisoschi Matei , Cristina Staicu Daniela , Peretianu Dan

Aim: To find if testosterone undecanoat 1000 mg injection (Nebido; Bayer-Schering) has a negative effect on prostate.Materials and methods: i) PSA (ng/ml) was registred retrospective (from files) and prospective analysis (onset 2010). ii) From over 175 patients to whom testosterone undecanoate 1000 mg, i.m. was administrated at 3 months, in the last 4 years, and to whom the prostatic volume was quantified (Journal of Sexual Medicine8</st...

ea0016p772 | Thyroid | ECE2008

Usefulness of thyroid echographic pattern description: predictive value at onset and in the evolution of thyroid diseases

Peretianu Dan , Staicu Daniela Cristea , Carsote Mara

Objectives: The study of the real indications for thyroid ultrasound and in which pathological conditions the echography is of real use and not for abuse.Material and methods: In the last 10 years, over 13 000 echographies were performed in 5136 consecutive patients for ‘thyroid disturbances’. In a previous paper we described 7 echographic patterns for thyroid ultrasound (9th ECE). The diagnosis of Hashimoto’s thyroiditis (HT) was consider...

ea0014p339 | (1) | ECE2007

Thyroid investigation profile in patients with Hashimoto’s thyroiditis associated with other autoimmune disorders

Poiana Catalina , Peretianu Dan , Carsote Mara

Introduction: The prevalence of autoimmune disorders (AID) is more frequent in patients with Hashimoto’s thyroiditis (HT).Aim: To see if the clinical and biochemical aspects are different among the patients with HT and if they change related to the systemic or organ specific AID.Material and method: A. HT was diagnosed on antithyroperoxidase antibodies (ATPO) over 34 UI/ml. B. 491 patients with HT were investigat...

ea0014p340 | (1) | ECE2007

Ultrasound patterns in patients with autoimmune thyroiditis

Peretianu Dan , Carsote Mara , Poiana Catalina

Objectives: To analyze the conceptual frame for a correlation between thyroid echographic description and antithyroid peroxydase antibodies (ATPO) levels in Hashimoto’s thyroiditis (HT).Material-methods: A. 783 patients: 396 with HT (ATPO>34 UI/ml), 386-control (ATPO<34 UI/ml). B. Ultrasound aspects were described in 8 patterns: 0-thyroid lack; 1 – hypoechogenic and pseudonodular; 2 – hypoechogenic and homogenous; 3 &...

ea0063p301 | Reproductive Endocrinology 1 | ECE2019

After up to 11 years observation, testosterone undecanoat 1000 mg at 3 months did not increased Prostatic Specific Antigen level (January 2019)

Pisoschi Matei , Staicu Dana Cristina , Peretianu Dan , Oprisan Bogdan

Aim: Has testosterone undecanoat 1000 mg intramuscular injection (NebidoR; Bayer), 1 at 3month, negative effect on prostate? For this purpose, we appreciate the prostatic volume (see Pisoschi, this congress) and PSA (this study) in hypogonadic patients after testosterone injection up to 11 years.Material and method: A. PSA (ng/ml) was done in Bucharest accredited laboratories.B. Patients: PSA analysis was done before tre...

ea0063p302 | Reproductive Endocrinology 1 | ECE2019

Analysing by decade, testosterone undecanoat depot injectable does not increases prostate volume: Study during up to 11 years on hypogonadic patients. (January 2019)

Pisoschi Matei , Staicu Dana Cristina , Peretianu Dan , Oprisan Bogdan

Aim: Re-Analysing (study starting in 2007) the effect of injectable testosterone undecanoat depot (TUD) in hypogonadic patients.Material-method: A. Patients: at onset 278 men with hypogonadism (median: 61 y).B. Distribution: by decade (starting with 20y); no =6, 17, 25, 70, 86, 55, 18, 1.C. TUD (NebidoR-Bayer) 1000 mg injected one/3 months i.m.D. Prostate volume (PV) apprecia...